Advertisement

High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma

0

Complete response rate was 37 percent, and post-hoc end point of objective response rate was 89 percent

Nike Co-Founder And Wife Donate $2B to Cancer Research at OHSU, Largest U.S. University...

0
By I. Edwards HealthDay Reporter MONDAY, Aug. 18, 2025 (HealthDay News) — Nike co-founder Phil Knight and his wife, Penny, will donate $2 billion to...

Autoimmune Diseases Linked to Digestive System Cancers

0

Positive associations seen for celiac disease, SLE, T1D with pancreatic, esophageal, colon, liver, and hepatobiliary cancers

Missed Opportunity Common in Patients With High-Grade Serous Ovarian Cancer

0

43.2 percent missed opportunity rate reported for germline genetic testing, risk-reducing surgery in those with affected first-degree relative

Fewer Americans Are Drinking Alcohol as Health Concerns Rise

0
By I. Edwards HealthDay Reporter THURSDAY, Aug. 14, 2025 (HealthDay News) — Fewer U.S. adults say they drink alcohol, and more now believe that even...

Public Awareness Low About HPV, HPV Vaccination, HPV-Linked Cancer

0

34.3 and 37.6 percent of U.S. adults were reportedly unaware of HPV and lacked awareness about the HPV vaccine, respectively

Adenoma Detection Rate of Standard Colonoscopy Declines After Exposure to AI-Assisted Colonoscopy

0

Independent factors tied to adenoma detection rate include AI exposure, male versus female patient sex, patient age 60 years or older versus younger than 60

Public Believes Dermatologic Side Effects From Cancer Treatment Are Common

0

Findings seen among both those previously treated for cancer and cancer-naive people

Age, Disease Duration Are Predictors of CKD After Stem Cell Transplant

0

Age and hematologic disease length are positive predictors for CKD; acute lymphoblastic leukemia is a negative predictive factor

Mailed At-Home Test Kits Most Effective for Boosting Colorectal Cancer Screening

0

Findings compared with three opt-in screening strategies among average-risk adults aged 45 to 49 years